MedTrace Logo

The Effects of Noninvasive Neuromodulation on Mental Wellness, Behavior, and Electrophysiology

NCT06169631 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2023-12-13

No results posted yet for this study

Summary

The purpose of the study is to test the effects of brief, low-intensity transcranial focused ultrasound (TUS) on electrophysiological, behavioral, and cognitive markers related to anxiety disorders.

Conditions

  • Anxiety Disorders

Interventions

DEVICE

Gen0b

The ultrasound will be administered to the brain region of interest.

Sponsors & Collaborators

  • Sanmai Technologies PBC dba Sanmai

    lead INDUSTRY

Principal Investigators

  • Jay Sanguinetti, PhD · Sanmai Technologies PBC

  • Taylor Kuhn, PhD · Sanmai Technologies PBC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-04-29
Primary Completion
2024-03-31
Completion
2024-04-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06169631 on ClinicalTrials.gov